MEG3 and hepatocellular carcinoma: In vitro, deregulated expression of the lncRNA MEG3 in HCC was shown to have a functional impact, and a potential mechanism through which deregulated tissue-specific expression of miR-29a in HCC could epigenetically modulate MEG3 expression via promoter hypermethylation was established (Braconi et al., 2011).